Which has preferable valuation & earnings, CVRX or KIDS?

OrthoPediatrics has higher revenue and earnings than CVRx. OrthoPediatrics is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $56.65M 2.67 -$53.31M -$2.02 N/A OrthoPediatrics $243.30M 2.15 -$39.65M -$1.68 N/A

Is CVRX or KIDS more profitable?

OrthoPediatrics has a net margin of -16.31% compared to CVRx's net margin of -89.14%. OrthoPediatrics' return on equity of -7.01% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -89.14% -120.76% -48.38% OrthoPediatrics -16.31% -7.01% -4.86%

Does the media prefer CVRX or KIDS?

In the previous week, OrthoPediatrics had 5 more articles in the media than CVRx. MarketBeat recorded 7 mentions for OrthoPediatrics and 2 mentions for CVRx. CVRx's average media sentiment score of 0.94 beat OrthoPediatrics' score of 0.41 indicating that CVRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OrthoPediatrics 0 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation & earnings, DCTH or CVRX?

Delcath Systems has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Delcath Systems $85.23M 5.29 $2.70M $0.01 1,305.20 CVRx $56.65M 2.67 -$53.31M -$2.02 N/A

Is DCTH or CVRX more profitable?

Delcath Systems has a net margin of 0.62% compared to CVRx's net margin of -89.14%. Delcath Systems' return on equity of 0.51% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets Delcath Systems 0.62% 0.51% 0.46% CVRx -89.14% -120.76% -48.38%

Is CVRX or SI more profitable?

Shoulder Innovations has a net margin of -81.78% compared to CVRx's net margin of -89.14%. Shoulder Innovations' return on equity of -35.11% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -89.14% -120.76% -48.38% Shoulder Innovations -81.78% -35.11% -20.58%

Does the media refer more to CVRX or SI?

In the previous week, Shoulder Innovations had 1 more articles in the media than CVRx. MarketBeat recorded 3 mentions for Shoulder Innovations and 2 mentions for CVRx. CVRx's average media sentiment score of 0.94 beat Shoulder Innovations' score of 0.00 indicating that CVRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Shoulder Innovations 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation and earnings, CVRX or CV?

CapsoVision has lower revenue, but higher earnings than CVRx. CapsoVision is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $56.65M 2.67 -$53.31M -$2.02 N/A CapsoVision $13.56M 27.94 -$25.32M -$2.34 N/A

Is CVRX or CV more profitable?

CVRx has a net margin of -89.14% compared to CapsoVision's net margin of -198.87%. CapsoVision's return on equity of 0.00% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -89.14% -120.76% -48.38% CapsoVision -198.87% N/A -136.03%

Does the media prefer CVRX or CV?

In the previous week, CVRx and CVRx both had 2 articles in the media. CVRx's average media sentiment score of 0.94 beat CapsoVision's score of 0.93 indicating that CVRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CapsoVision 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, CVRX or ELMD?

Electromed has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $56.65M 2.67 -$53.31M -$2.02 N/A Electromed $71.75M 4.81 $5.15M $1.17 35.63

Is CVRX or ELMD more profitable?

Electromed has a net margin of 11.34% compared to CVRx's net margin of -89.14%. Electromed's return on equity of 15.71% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -89.14% -120.76% -48.38% Electromed 11.34% 15.71% 13.37%

CVRx (CVRX) Competitors

$5.69 -0.17 (-2.90%)

As of 10:51 AM Eastern

Compare

CVRX vs. KIDS, DCTH, SI, CV, and ELMD

Should you buy CVRx stock or one of its competitors? MarketBeat compares CVRx with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CVRx include OrthoPediatrics (KIDS), Delcath Systems (DCTH), Shoulder Innovations (SI), CapsoVision (CV), and Electromed (ELMD). These companies are all part of the "medical equipment" industry.

How does CVRx compare to OrthoPediatrics?

CVRx (NASDAQ:CVRX) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability and institutional ownership.

OrthoPediatrics has higher revenue and earnings than CVRx. OrthoPediatrics is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	2.67	-$53.31M	-$2.02	N/A
OrthoPediatrics	$243.30M	2.15	-$39.65M	-$1.68	N/A

75.3% of CVRx shares are held by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are held by institutional investors. 18.9% of CVRx shares are held by company insiders. Comparatively, 32.7% of OrthoPediatrics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

CVRx has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 1.03, indicating that its share price is 3% more volatile than the broader market.

OrthoPediatrics has a net margin of -16.31% compared to CVRx's net margin of -89.14%. OrthoPediatrics' return on equity of -7.01% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-89.14%	-120.76%	-48.38%
OrthoPediatrics	-16.31%	-7.01%	-4.86%

In the previous week, OrthoPediatrics had 5 more articles in the media than CVRx. MarketBeat recorded 7 mentions for OrthoPediatrics and 2 mentions for CVRx. CVRx's average media sentiment score of 0.94 beat OrthoPediatrics' score of 0.41 indicating that CVRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OrthoPediatrics	0 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

CVRx currently has a consensus price target of $11.50, suggesting a potential upside of 102.11%. OrthoPediatrics has a consensus price target of $24.44, suggesting a potential upside of 19.90%. Given CVRx's stronger consensus rating and higher probable upside, research analysts plainly believe CVRx is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73

Summary

OrthoPediatrics beats CVRx on 10 of the 17 factors compared between the two stocks.

How does CVRx compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

Delcath Systems has a net margin of 0.62% compared to CVRx's net margin of -89.14%. Delcath Systems' return on equity of 0.51% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.62%	0.51%	0.46%
CVRx	-89.14%	-120.76%	-48.38%

In the previous week, CVRx had 1 more articles in the media than Delcath Systems. MarketBeat recorded 2 mentions for CVRx and 1 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 1.87 beat CVRx's score of 0.94 indicating that Delcath Systems is being referred to more favorably in the media.

Company	Overall Sentiment
Delcath Systems	Very Positive
CVRx	Positive

Delcath Systems has a beta of 0.54, meaning that its share price is 46% less volatile than the broader market. Comparatively, CVRx has a beta of 0.8, meaning that its share price is 20% less volatile than the broader market.

Delcath Systems currently has a consensus target price of $22.50, indicating a potential upside of 72.39%. CVRx has a consensus target price of $11.50, indicating a potential upside of 102.11%. Given CVRx's stronger consensus rating and higher possible upside, analysts plainly believe CVRx is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00

61.1% of Delcath Systems shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 19.4% of Delcath Systems shares are owned by insiders. Comparatively, 18.9% of CVRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Delcath Systems has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$85.23M	5.29	$2.70M	$0.01	1,305.20
CVRx	$56.65M	2.67	-$53.31M	-$2.02	N/A

Summary

Delcath Systems beats CVRx on 11 of the 17 factors compared between the two stocks.

How does CVRx compare to Shoulder Innovations?

CVRx (NASDAQ:CVRX) and Shoulder Innovations (NYSE:SI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment.

75.3% of CVRx shares are owned by institutional investors. 18.9% of CVRx shares are owned by company insiders. Comparatively, 29.0% of Shoulder Innovations shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

CVRx presently has a consensus target price of $11.50, suggesting a potential upside of 102.11%. Shoulder Innovations has a consensus target price of $21.00, suggesting a potential downside of 3.60%. Given CVRx's stronger consensus rating and higher probable upside, equities analysts plainly believe CVRx is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Shoulder Innovations has a net margin of -81.78% compared to CVRx's net margin of -89.14%. Shoulder Innovations' return on equity of -35.11% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-89.14%	-120.76%	-48.38%
Shoulder Innovations	-81.78%	-35.11%	-20.58%

In the previous week, Shoulder Innovations had 1 more articles in the media than CVRx. MarketBeat recorded 3 mentions for Shoulder Innovations and 2 mentions for CVRx. CVRx's average media sentiment score of 0.94 beat Shoulder Innovations' score of 0.00 indicating that CVRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Shoulder Innovations	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Shoulder Innovations has lower revenue, but higher earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	2.67	-$53.31M	-$2.02	N/A
Shoulder Innovations	$53.89M	8.38	-$40.36M	-$166.96	N/A

Summary

Shoulder Innovations beats CVRx on 9 of the 16 factors compared between the two stocks.

How does CVRx compare to CapsoVision?

CVRx (NASDAQ:CVRX) and CapsoVision (NASDAQ:CV) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, media sentiment, valuation and risk.

In the previous week, CVRx and CVRx both had 2 articles in the media. CVRx's average media sentiment score of 0.94 beat CapsoVision's score of 0.93 indicating that CVRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CapsoVision	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CVRx has a net margin of -89.14% compared to CapsoVision's net margin of -198.87%. CapsoVision's return on equity of 0.00% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-89.14%	-120.76%	-48.38%
CapsoVision	-198.87%	N/A	-136.03%

75.3% of CVRx shares are held by institutional investors. 18.9% of CVRx shares are held by insiders. Comparatively, 2.3% of CapsoVision shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

CapsoVision has lower revenue, but higher earnings than CVRx. CapsoVision is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	2.67	-$53.31M	-$2.02	N/A
CapsoVision	$13.56M	27.94	-$25.32M	-$2.34	N/A

CVRx presently has a consensus target price of $11.50, indicating a potential upside of 102.11%. CapsoVision has a consensus target price of $8.50, indicating a potential upside of 12.08%. Given CVRx's stronger consensus rating and higher probable upside, equities research analysts plainly believe CVRx is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

CVRx beats CapsoVision on 11 of the 14 factors compared between the two stocks.

How does CVRx compare to Electromed?

CVRx (NASDAQ:CVRX) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

75.3% of CVRx shares are held by institutional investors. Comparatively, 40.8% of Electromed shares are held by institutional investors. 18.9% of CVRx shares are held by company insiders. Comparatively, 10.5% of Electromed shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Electromed has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	2.67	-$53.31M	-$2.02	N/A
Electromed	$71.75M	4.81	$5.15M	$1.17	35.63

CVRx presently has a consensus target price of $11.50, suggesting a potential upside of 102.11%. Electromed has a consensus target price of $37.50, suggesting a potential downside of 10.04%. Given CVRx's higher possible upside, equities research analysts clearly believe CVRx is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00
Electromed	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25

In the previous week, CVRx had 2 more articles in the media than Electromed. MarketBeat recorded 2 mentions for CVRx and 0 mentions for Electromed. CVRx's average media sentiment score of 0.94 beat Electromed's score of 0.00 indicating that CVRx is being referred to more favorably in the media.

Company	Overall Sentiment
CVRx	Positive
Electromed	Neutral

Electromed has a net margin of 11.34% compared to CVRx's net margin of -89.14%. Electromed's return on equity of 15.71% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-89.14%	-120.76%	-48.38%
Electromed	11.34%	15.71%	13.37%

CVRx has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market. Comparatively, Electromed has a beta of 0.53, meaning that its stock price is 47% less volatile than the broader market.

Summary

Electromed beats CVRx on 10 of the 17 factors compared between the two stocks.

Get CVRx News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CVRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CVRX vs. The Competition

Export

Metric	CVRx	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$150.22M	$7.36B	$6.84B	$12.34B
Dividend Yield	N/A	1.25%	2.67%	6.11%
P/E Ratio	-2.80	51.38	25.87	24.19
Price / Sales	2.67	49.70	553.99	100.49
Price / Cash	N/A	26.99	29.09	36.93
Price / Book	3.79	7.58	10.79	6.42
Net Income	-$53.31M	$159.19M	$3.58B	$337.00M
7 Day Performance	17.08%	2.40%	2.49%	0.94%
1 Month Performance	1.97%	-2.72%	0.21%	-0.66%
1 Year Performance	-2.23%	5.76%	35.20%	27.96%

CVRx Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CVRX CVRx	3.1038 of 5 stars	$5.69 -2.9%	$11.50 +102.1%	+0.7%	$150.22M	$56.65M	N/A	160	News Coverage Analyst Upgrade
KIDS OrthoPediatrics	3.2132 of 5 stars	$18.43 +1.5%	$24.44 +32.6%	-5.0%	$473.38M	$243.30M	N/A	200	Gap Down
DCTH Delcath Systems	2.548 of 5 stars	$12.18 +5.8%	$22.50 +84.7%	-4.6%	$420.45M	$85.23M	1,218.00	60	Positive News
SI Shoulder Innovations	1.4905 of 5 stars	$19.09 +7.4%	$21.00 +10.0%	N/A	$395.89M	$53.89M	N/A	61	News Coverage Gap Down
CV CapsoVision	0.9017 of 5 stars	$6.56 +1.2%	$8.50 +29.6%	N/A	$327.76M	$13.56M	N/A	90

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CVRX) was last updated on 6/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CVRx (CVRX) Competitors

CVRX vs. KIDS, DCTH, SI, CV, and ELMD

How does CVRx compare to OrthoPediatrics?

Summary

How does CVRx compare to Delcath Systems?

Summary

How does CVRx compare to Shoulder Innovations?

Summary

How does CVRx compare to CapsoVision?

Summary

How does CVRx compare to Electromed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CVRX vs. The Competition

CVRx Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CVRx (CVRX) Competitors

CVRX vs. KIDS, DCTH, SI, CV, and ELMD

How does CVRx compare to OrthoPediatrics?

Which has preferable valuation & earnings, CVRX or KIDS?

Do institutionals & insiders hold more shares of CVRX or KIDS?

Which has more risk and volatility, CVRX or KIDS?

Is CVRX or KIDS more profitable?

Does the media prefer CVRX or KIDS?

Do analysts rate CVRX or KIDS?

Summary

How does CVRx compare to Delcath Systems?

Is DCTH or CVRX more profitable?

Does the media refer more to DCTH or CVRX?

Which has more risk & volatility, DCTH or CVRX?

Do analysts recommend DCTH or CVRX?

Do insiders & institutionals have more ownership in DCTH or CVRX?

Which has preferable valuation & earnings, DCTH or CVRX?

Summary

How does CVRx compare to Shoulder Innovations?

Do institutionals & insiders hold more shares of CVRX or SI?

Do analysts recommend CVRX or SI?

Is CVRX or SI more profitable?

Does the media refer more to CVRX or SI?

Which has preferable earnings & valuation, CVRX or SI?

Summary

How does CVRx compare to CapsoVision?

Does the media prefer CVRX or CV?

Is CVRX or CV more profitable?

Do insiders & institutionals believe in CVRX or CV?

Which has preferable valuation and earnings, CVRX or CV?

Do analysts recommend CVRX or CV?

Summary

How does CVRx compare to Electromed?

Do insiders and institutionals have more ownership in CVRX or ELMD?

Which has stronger earnings & valuation, CVRX or ELMD?

Do analysts rate CVRX or ELMD?

Does the media favor CVRX or ELMD?

Is CVRX or ELMD more profitable?

Which has more volatility and risk, CVRX or ELMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CVRX vs. The Competition

CVRx Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools